论文部分内容阅读
“重大新药创制”专项旨在全面提升我国的新药创新与研发能力,特别是在全国范围内布局了15个“综合性新药研究开发技术大平台”。本文通过研究“大平台”承担机构2007～2011年申请的药学领域的专利情况,分析各机构药学专利申请总量和专利技术点,以期能为客观评估“重大新药创制”专项的实施绩效与发展潜力提供参考依据,为专项今后的布局与实施提供参考,并指出大多数机构对国内优先权专利及国际专利的申请还不够重视。
The project of “major new drug creation” aims at comprehensively enhancing the innovation and R & D capability of new drugs in our country, in particular, laying out 15 “Comprehensive New Drug Research and Development Technology Platform” across the country. This paper analyzes the patent applications filed by the institute from 2007 to 2011 in the field of pharmacy, and analyzes the total number of patent applications and patenting points in each institution so as to objectively evaluate the implementation of the special project of “major drug creation” Performance and development potential, provide a reference for the future layout and implementation, and point out that most of the agencies do not pay enough attention to the applications of domestic priority patents and international patents.